诚意药业(603811.SH)发布半年度业绩,归母净利润1.12亿元,同比增长47.03%
Cheng Yi PharmaCheng Yi Pharma(SH:603811) 智通财经网·2025-08-26 12:50

Core Insights - The company reported a revenue of 417 million yuan for the first half of 2025, representing a year-on-year growth of 17.11% [1] - The net profit attributable to shareholders reached 112 million yuan, showing a significant year-on-year increase of 47.03% [1] - The net profit excluding non-recurring items was 111 million yuan, which is a year-on-year growth of 54.21% [1] - The basic earnings per share stood at 0.35 yuan [1]